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vAbstract
A genetically diverse community of commensal and pathogenic bacteria
thrive in the digestive system and urogenital tracts of animals. Many of
these bacteria forage sialic acid from mucosal cell surfaces. Bacteria have
evolved a system that utilizes host-derived sialic acid either as an alterna-
tive food source (catabolic pathway) or for molecular mimicry to evade the
host’s immune system (sialylation pathway). Their ability to utilize sialic
acid confers a selective advantage by securing an ecological niche for col-
onization and persistence. Sialic acid catabolic and sialylation pathways
are therefore potential targets for the development of novel antimicrobial
therapies.
This thesis presents work aimed at determining X-ray structures of sialic
acid catabolic enzymes and sialic acid transporters. An automated pipeline
was developed to optimize the cloning, expression and purification of en-
zymes involved in the sialic acid catabolic and sialylation pathways. This
led to the large scale production and purification of Nan kinase from Fu-
sobacterium nucleatum (Fn)NanK, an enzyme that phosphorylates ManNAc
to ManNAc-6-P in the catabolic pathway. The apo structure of FnNanK was
determined at 2.2 Å resolution and displays motifs characteristic of the re-
pressor open reading frame kinase (ROK) superfamily. Despite lacking a
zinc-binding region previously implicated in stabilizing the enzyme’s ac-
tive site, FnNanK conserved all structural features required for enzymatic
activity. A broad base strategy for the expression, solubilization and purifi-
cation of a sialic acid TRAP transporter orthologues was pursued with the
overriding goal of determining the crystal structure of a sialic acid TRAP
transporter. Different constructs from four orthologues funneled down to
the Pasteurella multocida TRAP transporter yielding crystals which diffracted
vi
to 11 Å resolution. New crystallization strategies or other structural ap-
proaches may be necessary to propel this project to structure determination.
Finally, the crystal structure of the sialic acid transporter SiaT from Proteus
mirabilis was determined at 1.9 Å with bound substrate. SiaT adopts an
outward-facing conformation that provides novel insight into the alternate
access mechanism employed by transporters with inverted topology. The
crystal structure also reveals a second sodium-binding site that aids sub-
strate binding and stabilizes the outward-facing conformation.
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1Chapter 1
Introduction
Billions and billions of microorganisms thrive in the Earth’s biosphere [1].
Within this vast number, microbial diversity is indispensable for the bacte-
ria’s survival and proliferation. Bacteria constantly adapt and compete to
secure ecological niches wherein through the process of natural selection,
new phenotypes are acquired that confer fitness advantage.
Antibacterial therapy promotes such selection pressure on bacteria by
counteracting its cytotoxic and cytostatic effects rendering the bacteria sus-
ceptible to the host immune response. Antibiotics typically work by inhibit-
ing cell wall biosynthesis, disrupting nucleic acid and protein synthesis or
other specific actions [2]. Resistance mechanisms against the actions of an-
tibiotics are developing through a selection process.
The resistance mechanisms include diminished uptake of the antibiotics
through low permeability of the outer membrane, efflux pumping to expel
antibiotics out of the cytoplasm, impeding the binding of the antibiotics by
modifying the target sites and expression of enzymes that inactivate antibi-
otics [3]. Antibiotic resistance arises when the ability of the drug to effec-
tively inhibit bacterial growth is seriously compromised. Consequently, a
higher concentration of antibiotics is needed to decrease the rate of bacterial
replication. In addition, resistance can be acquired against more than one
antibiotic drug simultaneously giving rise to multidrug resistant bacteria
designated as ‘superbugs’ [4, 5].
Antibiotic resistance remains a global health threat that is gaining an
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alarming momentum due to the misuse and overuse of the currently avail-
able antibiotics [6]. Infectious diseases continue to be one of the leading
causes of death worldwide. The reemergence of the once contained dis-
eases serve as a stark warning on what is to spiral out of control in an un-
precedented global scale. Thus, the pressing antibiotic resistance problems
need to be curbed on time. Since the late 1980s, no new antibiotics were
discovered while one by one the presently available antibiotics become in-
effective against to multidrug resistant bacteria, the antibiotic Ceftaroline
being the latest one [2].
1.1 Antibiotics resistance spreads via horizontal
gene transfer
The bacteria’s ability to diversify in order to adapt and thrive in special
niches and compete for the resources and acquire physiological traits that
enhance virulence reflects the innovative nature of the bacterial genome
propelled by lateral gene transfer. Through plasmids, integrons and trans-
posable elements, fitness factors such as multidrug resistance are trans-
ferred [7].
There is a constant shuffling and reshufflings in the bacterial genome
wherein genes that do not hold essential functions are segregated and deleted
to be replaced by genes that endow cells with a fitness advantage [7]. DNA
sequences encoding important protein factors such as resistance traits and
new metabolic pathways are driven forward by natural selection. In bacte-
ria it is a constant balancing act between genes acquired and genes lost. In
this regard, lateral gene transfer contributes to the adaptability and specia-
tion.
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1.2 Virulence in host-microbe interaction
What is virulence? Virulence is the degree of damage inflicted on the host
by any microbe capable of causing the disease. The definition of virulence
is a two-way street wherein the invasiveness of the pathogen is largely de-
pendent on the susceptibility of the immune response of the host under the
attack [8].
Virulence mechanisms under host-microbe interaction largely consti-
tutes of the use of microbial adhesins as a first line of contact to the host cell
and the release of toxins to impair the host cells. It also includes any type
of invasion of the innate and immune response and the upregulation of
virulence-associated genes and secretion of virulence enhancing products
[9]. Targeting any of the aforementioned virulence mechanisms can restrict
or inhibit the pathogen’s persistence and eventually prevent the disease.
In this connection, bacterial sialobiology has a convincing role to play in
developing new therapeutic interventions in preventing diseases and infec-
tions [10]. Many bacterial commensals and pathogens utilize sialic acid for
persistence and to increase their pathogenicity. Sialic acid, which is abun-
dant in the eukaryotic host, is acquired by both commensals and pathogens
to be used as a food source (catabolic pathway) or as molecular mimicry
(sialylation) as effective mechanism for colonization and persistence. Tar-
geting these pathways can be instrumental in designing novel drugs for
antimicrobial therapy.
1.3 What is sialic acid?
Sialic acid is the designation for a family of nine-carbon α-keto amino sug-
ars. It is abundant in nature except in plants. It is mainly found within the
deuterostome lineage under the domain Eukarya [11]. Scaffolding its struc-
tural diversification and modification is the core moiety of 2-keto-3-deoxy-
5-acetamido-D-glycero-D-galacto-nonulosonic acid or N-acetylneuraminic
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Figure 1.1: The most common types of sialic acids.
acid (Neu5Ac). (Figure 1.1). Serving as a precursor for any structural mod-
ification, Neu5Ac constitutes a 6-carbon carboxylic acid ring with an ac-
etamido on C5 and a glycerol tail with hydroxyl groups C7, C8 and C9 [12].
Modifications in C5 position are prevalent and the most common ones are
the substitution with a hydroxyl group forming N-glycolylneuraminic acid
(Neu5Gc) [11].
Interestingly, Neu5Gc is ubiquitous in the deuterostome lineage but miss-
ing in humans. The distinct absence of Neu5Gc in humans is attributed
to the deletion of the 92 bp exons in the hydroxylase gene rendering the
enzyme that converts Neu5Ac to Neu5Gc inactive [13]. However trace
amounts of Neu5Gc are detected in human tissues that are accounted to
the dietary intake of mostly red meat [13, 14]. Further structural diversity
extends to with the deaminated group of Neu5Ac and O-acetylation.
1.4 Sialic acid in vertebrates
Epithelial mucosal cell surfaces are studded with sialic acid serving as the
terminal non-reducing sugar of the glycoproteins and glycolipids. Due to
its location, sialic acid has an essential role in cell-cell interactions and self-
recognition functions in numerous biological regulatory processes that is
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crucial in maintaining homeostasis.
In humans, the most abundant source of sialic acid is in the form of
polysialic acid (PSA) that is found in the brain. PSA is involved in cell
signaling processes that are implicated in neural plasticity, growth and mi-
gration throughout the central nervous system (CNS) [15].
Additionally, glycoconjugates found in GD3 gangliosides carry the O-
acetylated sialic acid. GD3 acts as a stress-induced apoptosis mediator by
accumulating in the mitochondria and thereby compromising the integrity
of the plasma membrane causing the release of apoptotic factors and cas-
pases triggering Fas-mediated apoptosis [16, 17].
The role of sialic acid in self-recognition function is demonstrated in
the down regulation of the alternative complement pathway through the
binding of the Factor H to the glycerol tails of sialic acid. Studies reported
that 9-O acetylation impedes the binding of Factor H thereby activating the
innate immune response. Pathogenic bacteria that lack a coat of sialic acid
and consequently are not recognized by Factor H, fail to evade the immune-
surveillance and thus are subject to lysis via the complement system [18].
Another type sialic-acid binding protein found in the vertebrates is se-
lectin. This family of lectins binds to sugar moieties such sialyl lewis x and
sialyl lewis A on the cell surfaces. Selectins are expressed in leukocytes,
activated platelets and endothelial cells. They are activated as the first line
of defense of the immune system to recruite leukocytes to the inflammed
region [16, 19, 20].
In addition, Siglecs is the largest family of mammalian sialic acid bind-
ing lectins. Interaction between the sialoglycoconjugates and CD33-related
siglecs leads to inhibitory mechanism by enhancing the production of anti-
inflammatory cytokines and diminishing the secretion of pro-inflammatory
cytokines [21, 22].
1.5 De novo biosynthesis of sialic acid
The synthesis of Neu5Ac from UDP-GlcNAc involves five steps enzymatic
reactions (Figure 1.2). In the cytoplasm UDP-GlcNAc from the hexosamine
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pathway is epimerized by UDP-GlcNAc-2-epimerase yielding ManNAc and
releasing UDP. Instantly, ManNAc is phosphorylated using ATP by ManNAc
kinase producing ManNAc-6-phosphate. In humans, conversion of UDP-
GlcNAc to ManNAc-6-phosphate is catalyzed by a bifunctional enzyme
GNE [23]. Next, Neu5Ac9P synthase catalyzes the condensation of ManNAc-
6P and phosphoenolpyruvate (PEP) yielding Neu5Ac9P. The 9-phosphate
from Neu5Ac9P is then released by a phosphatase. The activation of Neu5Ac
to CMP-Neu5Ac occurs in the nucleus where the cytidine triphosphate (CTP)
and Neu5Ac are joined by CMP-Neu5Ac synthetase and the pyrophosphate
is released by a phosphatase yielding CMP-Neu5Ac. Afterwards the nu-
cleotide sugar is then transported into the Golgi body with the aid of CMP-
Neu5Ac transporters. Once inside the Golgi apparatus, activated CMP-
Neu5Ac is used as a substrate by sialyltransferases to proceed to glycosyla-
tion [23].
In vertebrates, Neu5Ac degradation is catalyzed by an aldolase, split-
ting Neu5Ac to ManNAc and PEP. ManNAc is then converted to GlcNAc
by GlcNAc-2-epimerase and subsequently phosphorylated to GlcNAc-6P
by a kinase whereby it enters the hexosamine pathway [16, 24].
Although rare, there are bacteria that are capable of synthesizing Neu5Ac
de novo. The E.coli serotype K1 strain and some Nesseria strains have a
biosynthetic pathway that utilizes homologues of UDP-GlcNAc-2-epimerase,
Neu5Ac-9P-synthase and CMP-Neu5Ac-synthase. In prokaryotes, ManNAc
is directly converted to Neu5Ac and immediately activated to CMP-Neu5Ac
whereas in eukaryotes, the intermediate steps require certain phosphatases.
The more rapid activation of Neu5Ac reflects the different fates of sialic
acid between higher eukaryotes and bacteria. Cleaved sialic acid is either
secreted or directed to lysosomes for recycling in eukaryotes while the mi-
crobes utilize sialic acid for molecular mimicry and as a nutritional source.
In addition, bacteria have evolved dynamic modes of transport of the scav-
enged sialic acid [26].
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Figure 1.2: Sialic acid biosynthesis and metabolism in eukaryotes. The
synthesis of Neu5AC from UDP-GlcNAc takes place in the cytoplasm (yel-
low background) while exogenous Neu5AC from the glycoconjugates (blue
background) is acquired via the lysosomes. Neu5AC is activated in the nu-
cleus and then transported to the Golgi body to proceed to glycosylation.
(Reproduced from Petit, et al) [25].
1.6 Sialylation
Higher eukaryotes decorate their cell surfaces with sialic acid, a process
that occurs in the Golgi apparatus (Figure 1.3). The physicochemical prop-
erties of an activated CMP-Neu5Ac impede its diffusion across the Golgi
membrane. Hence a specific CMP-Neu5Ac transporter facilitates its entry
into the cytoplasm. Once recognized by sialyltransferase as a substrate, it is
incorporated onto the terminal region of the glycoproteins and glycolipids
[27].
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Figure 1.3: Bacterial sialylation in three types of surface structures;
lipopolysaccharide, flagellar and capsular. (Reproduced from Haines-
Menges et al [22]).
Since the outermost layer of mucosal surfaces in an animal host are sat-
urated with sialic acid, it is not surprising that bacteria have evolved mech-
anisms to exploit this monosaccharide to their own advantage. Bacteria use
adhesins to establish the first line of contact with the target cell. Sialidases
are then produced by the bacteria to cleave sialic acid from the cell surface’s
glycoconjugates. Subsequently, the acquired sialic acid is transported into
the cytoplasm to be used either for sialylation or foodstuff [14, 28].
Sialylation in bacteria occurs in three types of surface structures de-
pending on the strain and species such as lipopolysacharride LPS in gram-
negative bacteria, flagella and capsular polysaccharide [22]. Moreover, trans-
port of Neu5Ac into the cytoplasm in Tanerella forsythia is reported to be
important for biofilm formation and survival in epithelial cells [29].
Bacteria have adapted four main mechanisms for obtaining sialic acid:
de novo biosynthesis, donor scavenging, trans-sialidase and precursor scav-
enging [30]. De novo biosynthesis of sialic acid is observed in E.coli K1
strain and other Nesseria strains wherein endogenous Neu5Ac is activated
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Figure 1.4: The sialic acid catabolic pathway. Degradation of Neu5Ac occurs
in five steps yielding Fructose-6-P. The degradation is regulated by nan-nag
cluster.(Adapted from Vimr [14])
by CMP-Neu5Ac synthetase and recognized by sialyltransferases as a sub-
strate and then incorporated into the terminal end of the glycan moiety.
Donor scavenging is observed in N. gonorrhea where its resistance to com-
plement serum is restored after addition of exogenous CMP-Neu5Ac, us-
ing its own sialyltransferases to decorate cell surfaces. The trans-sialidase
mechanism is demonstrated by T. cruzi with no inherent sialic acid biosyn-
thesis and catabolic regulon, it hydrolyzes sialyl unit from the host’s glyco-
conjugates to reconstruct its cell surface .
Moreover, H. influenzae lacks sialidases and cannot synthesis Neu5Ac de
novo, however it carries a Neu5Ac degradation system utilizing it as carbon
and nitrogen source. Apart from this, H. influenzae encodes its own CMP-
Neu5Ac synthetase and sialyltransferase indicating its capability to incor-
porate Neu5Ac onto its cell surface. Scavenged Neu5Ac are either directed
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to degradation or sialylation [27].
1.7 Sialic acid catabolism
The ability to use sialic acid as an alternative food source is instrumental
for many types of bacteria’s colonization and persistence. Studies report
a direct correlation between pathogen’s enhanced virulence and sialic acid
catabolism [22, 28].
Once bound sialic acid is cleaved by the sialidases from the host mu-
cosal cell surface, the amino sugar is transported by permeases into the cy-
toplasm. Afterwards, N-acetylneuraminate lyase (NanA) cleaves Neu5Ac
into ManNAc and pyruvate, the latter then enters the TCA pathway. ManNAc
proceeds to be phosphorylated by N-acetylmannosamine kinase (NanK)
yielding ManNAc-6P which is then epimerized to GlcNAc-6P by N-acetyl-
mannosamine-6-phosphate-2-epimerase (NanE). The nag operon is induced
by GlcNAc-6P, which encodes the N-acetylglucosamine-6P deactylase (NagA)
and subsequently the glucosamine-6P-deaminase (NagB) that breaks down
GlcNAc-6P to fructose 6-P and ammonia. (Figure 1.4)[14].
1.8 Bacterial sialometabolism in mucosal cell
surfaces
Starting from the mouth, the oral pathogen that causes inflamed gums T.
forsythia is widely implicated in biofilm formation. Its genome encodes for
sialidases, sialic acid transporter and sialic acid catabolism. Mutation stud-
ies in its sialidases indicated terminal growth in media with sialic acid as
a sole carbon source and a hampered ability to adhere on cell surfaces [31,
32].
Passing through the respiratory tract where the pathogen non-encapsula-
ted H. influenzae could establish a niche, causes bronchitis and otitis media.
Although primarily a sterile environment, the respiratory tract’s mucosal
linings, which are rich in sialic acid are a good habitat for H. influenzae. The
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Figure 1.5: The sialic acid regulon
scavenged sialic acid ends up either as surface decoration or food source.
Studies where in the first committed degradation enzyme NanA is deleted
increased sialylation and consequently serum resistance was observed [22,
33, 34].
The mucosal layer of the gastrointestinal tract functions as a protective
barricade for infections. Diverse microbes have inhabited the spanning
length of the gastrointestinal tract as their niches, whose rich diversity is
comparable to the stratified species variation of a rainforest [10, 35]. The
most dominant Gram-negative facultative commensal in the human gut is
E.coli K12, its ability to use sialic acid as an alternative food source gives
E.coli K12 a competitive edge, thus securing the GIT as its niche [14]. An-
other known gut pathogen S. enterica, enhances its virulence by utilizing
Neu5Ac for adhesion and colonization [36].
Worth mentioning is the colonization of the gut by the Vibrio sp. Encod-
ing the sialoregulon in their genome, V. cholera shows a growth advantage
during the early stages of infections upon utilization of sialic acid [26]. Fur-
ther, NanA lyase mutations in V. vulnificus reported diminished virulence
and susceptibility to cytotoxic response. NanA lyase experiments suggest
that NanA, whose transcription is induced by the presence of sialic acid, is
necessary for growth in minimal medium supplemented with sialic acid as
the sole carbon source [22, 37].
Thriving in the urogenital tract is G. vaginalis, the causative agent for
bacterial vaginosis which uses endogenous sialidases to acquire sialic acid
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which is then degraded to carbon and nitrogen source. Furthermore, in-
creased virulence is implicated as the sialidases attacks the mucosal protec-
tive barrier by foraging sialic acid into depletion [38].
Taken together, the ability to utilize sialic acid by the commensal and
pathogenic bacteria as an alternative food source confers a competitive ad-
vantage that leads to securing niches that span the entire mucosal layer in
a vertebrate.
1.9 The canonical nan operon in E. coli K12
The nan operon is a sialic acid regulating gene cluster consisting of nanATEK-
yhcH and a nanR repressor located upstream. NanR repressed the tran-
scription of nanA by binding onto the operator, thereby blocking the RNA
polymerase that transcribes NanA. More recently, a corregulated sialic acid
operon nanCMS yjhBC was identified (Figure 1.5) [14, 39]. In this nan
operon, NanC encodes for an outermembrane porin, NanM for a sialate
mutarotase and NanS for a sialate O-acetyl esterase. The crystal structure
of 12 stranded beta-barrel NanC belongs to a family of diffusion channels
with high selectivity for acidic oligonucleotide [40, 41].
Generally sialic acid is released as an α-anomer from the host glyco-
conjugates but imported by the transporters into the cytoplasm in its β-
anomeric form [14, 42]. Spontaneous rotation from the α-anomeric form
to the β-anomeric occurs at a slow pace but with the aid of NanM the
rapid conversion of α-anomeric sialic acid to β-anomeric structure boosts
the scavenging mechanism of the commensals and pathogens alike, confer-
ring a competitive edge.
Further, NanS converts O-acetylated sialic acid to Neu5Ac and the yhcH
gene is possibly an epimerase as its crystal structure indicates an epimerase
activity [43]. Similar to nanT, gene yjHB possibly transports a distinct type
of sialic acid while gene yjhc is a putative oxidoreductase.
As proposed, the sialocatabolic pathway starts with the transport of free
flowing sialic acids into the periplasm by outer membrane proteins OmpF,
OmpC and NanC through passive diffusion. In the periplasm, sialic acids
1.10. Sialic Acid Transporters 13
Figure 1.6: The proposed mechanism of sialic acid catabolic pathway. The
uptake of sialic acid into the periplsm by nan porins, followed by the con-
vertion of sialic acid to recognizable substrates for the sialic acid transporter.
NanA cleaved Neu5Ac to ManNAc and pyruvate.
are converted by NanS and NanM into recognizable substrates for NanT
and possibly also for Yjhb, to be transported into the cytoplasm. Once in-
side the cytoplasm Neu5Ac is cleaved by NanA to ManNAc and pyruvate.
The resulting ManNAc is finally degraded into carbon, nitrogen and energy
(Figure 1.6) [14].
1.10 Sialic Acid Transporters
Bacteria have devised diverse ways of adaptation for growth and survival
in response to a dynamically changing environment where the resources
are limited and the competition is fierce. Many commensals and pathogenic
bacteria occupy niches and persist in mucin-rich environments such as gas-
trointestinal and respiratory tracts of humans and other members of the
deuterostome lineage. In higher eukaryotes, the cell surface glycans have
sialic acid as its terminal sugar. Bacteria exploit the externally acquired
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sialic acid by using it as molecular mimicry to bypass the immunosurveil-
lance of the host or as an alternative source for carbon, nitrogen and energy
[14, 22, 34, 44].
The uptake of the externally acquired sialic acid requires a functional
sialic acid transporter to move the sugar across the membrane into the
cytoplasm. Throughout the bacterial kingdom, there are various ways of
transporting sialic acid into the cytoplasm. To date, there are four known
families of sialic acid transporters representing both primary and secondary
transporters [45, 46]. The family of ATP-binding cassette (ABC) transporters
is the primary transporter in which that the hydrolysis ATP drives the trans-
port of the sugar into the cytoplasm [47]. Representing the secondary trans-
porters are the tripartite-ATP-independent periplasmic (TRAP) transporters,
major facilitator superfamily (MFS) and the sodium solute symporters (SSS)
[46]. All secondary transporters harness the energy from the electrochemi-
cal gradient to drive on transport across the membrane.
In order for bacteria to exploit sialic acid, an active sialic acid transporter
is necessary to move the sugar into the cytoplasm where it can end up in
two different pathways: the sialylation pathway or the catabolic pathway
[26, 28]. Mutation studies that lead to loss of function of the sialic acid
transporters demonstrate the capacity to utilize sialic acid is linked to its
ability to transport the sugar into the cytoplasm. Disruption in the uptake
function of nanT sialic acid transporter in E. coli results in the bacteria’s
inability to grow on sialic acid as the sole carbon source [39]. Mutation
and the subsequent disruption of the sialic acid TRAP transporter in H.
influenza, diminished sialylation that results in bacteria’s high sensitivity of
bacteria to human serum [48]. In a separate growth assay, the sialic acid
transporter gene from Salmonella enterica serovar Typhimurium was able to
restore growth on sialic acid as a sole source of carbon in ∆nanT deleted E.
coli strain [49].
Humans are capable of de novo biosynthesis of sialic acid and also have
corresponding sialic acid transporters that have a low homology with the
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bacterial sialic acid transporters. Development of novel inhibitors that inac-
tivate the sialic acid transporters in bacteria and thereby reduce its pathogenic-
ity, is a promising target for drug development. In this section, the different
types of sialic acid transporters are introduced providing a background to
Paper 3 and Paper 4 (Chapters 4 and 5).
1.10.1 Outer membrane protein
In Gram-negative bacteria there is an additional outer membrane layer that
controls the traffic of molecules into and out of the periplasmic space. There
are outer membrane porins that are used for the efficient uptake of sialic
acid into the periplasm. The porin NanC [40, 41] encoded from the sialic
acid operon nanCMS facilitates the movement of sialic acid across the out-
ermembrane. Once inside, the α-anomeric sialic acid is converted to β-
anomeric sialic acid by a mutarotase NanM from the same operon, prior
to the sugar’s uptake into the cytoplasm [50].
More recently, the outermembrane nanOU system was identified as a
sialic acid transport system in T. forsythia and B. fragilis. The nanOU system
consists of two subunits; the NanO, a Ton-B dependent porin and a NanU,
a sialic acid binding protein that captures sialic acid with high affinity then
delivers it onto the porin to be translocated into the periplasm (Figure 1.7)
[51].
1.10.2 ABC transporters
The sialic acid ABC transporter is encoded by the operon satABCD wherein
the SatA is a subsrate binding protein for high affinity capture of sialic acid
in the periplasm. The SatB subunit is an integral membrane protein that
translocates the substrate into the cytoplasm while SatD subunit is the nu-
cleotide binding domain. In addition, SatC subunit is a fusion between a
permease and a nucleotide binding domain (Figure 1.7) [52].
Sialic acid ABC transporters are present in a wide range of bacteria such
as the genus Streptococcos, Corynebacterium, Actinobacillus and Haemophilus
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Figure 1.7: Sialic acid transporters. The NanC and NanOU porins in the
outer membrane import sialic acid into the cytoplasm. Enzymes NanM and
NanS convert sialic acid to recognizable substrate prior to transport into the
cytoplasm. Different types of sialic acid transporters, MFS, TRAP, ABC and
SSS have various mode of substrate transport. (Adapted from North et. al
[45])
[53, 54]. This was first characterized in H. ducreyi as it was demonstrated to
be essential for its sialylation [52].
1.10.3 TRAP transporters
The TRAP transporter was first characterized in the C4-dicarboxylate trans-
porter in Rhodobacter capsulatus [55]. As a secondary transporter, the trans-
port of the substrate across the membrane is driven by an electrochemical
gradient. Moreover, TRAP transporters are prevalent in bacteria and archae
but are absent in eukaryotes. It transports a wide range of solutes such as
amino acids, C4-dicarboxylate, ectoine, gluconate, aromatic substrate and
sialic acid [56, 57].
The sialic acid TRAP transporter is composed of three subunits. Like
the ABC transporter, it has a substrate-binding domain SiaP that captures
sialic acid with high affinity in the periplasm and delivers it onto the inter-
gral membrane domains. Structural studies on the SiaP subunit indicate a
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highly conserved salt bridge formation between an Arg and the carboxylate
group of the substrate (Figure 1.7) [58, 59]. In H. influenzae, P. multocida and
F. nucleatum, these two integral membrane components are fused forming
a single subunit while in V. cholera the integral membrane components are
two separate subunits making it a true tripartite system. Topology predic-
tion for the transmembrane domains indicates 17 transmembrane helices
(TMHs). The small SiaQ domain is made up of 4 TMHs while the large
SiaM domain is composed of 12 TMHs. The two domains are fused with an
extra helix. Interestingly, the SiaM domain is the translocator and belongs
to the IT superfamily of proteins while the SiaQ domain has an unclear
function [60].
Mutations on the substrate binding SiaP or in the transmembrane do-
mains result in the loss of sialic acid uptake, which leads to decreased sialy-
lation and subsequently high sensitivity to human serum [48, 56]. In chin-
chilla model of otitis media, disruption of the TRAP transporter in H. in-
fluenzae decreases its virulence [61].
1.10.4 Major Facilitator Superfamily
In 1985, the first sialic acid transporter NanT was experimentally character-
ized in E. coli [39]. The sialic acid transporter was identified by isolating E.
coli mutants with knock out function of Neu5Ac uptake and consequently
by mapping the mutation to the locus designated as nanT. The sialic acid
NanT is a member of the MFS superfamily. A unique feature of NanT is
that it is comprised of 14 TMHs instead of the more common 12 TMHs in
the MFS family. The proposed translocation mechanism that is employed
within this family, is the “rocker switch” mechanism [62, 63] in which the
inward and outward facing conformations alternate and the substrate bind-
ing site can only be reached in a successive manner. In Tanerella forsythia,
NanT is important for the biofilm formation and enhanced virulence (Fig-
ure 1.7) [29] .
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1.10.5 Sodium Solute Symporter
More recently, the newest addition to the types of sialic acid transporter
is the sodium solute symporter (SSS) family, first characterized in S. enter-
ica serovar Typhimurium [49]. SiaT is utilized by a broad spectrum of both
Gram-negative and gram- positive bacteria such as S. aureus [64], C. difficile
[65], V. fischeri [26], L. sakei [66] and P. profundum [26]. As a sodium sym-
porter, it transports sodium ions together with the substrate driven by the
sodium gradient across the membrane (Figure 1.7) [49].
There is one known crystal structure of an SSS transporter, the V. para-
haemolyticus sodium galactose symporter (SGLT) [67]. It is an inward-facing
structure and the core domain structure of vSGLT is comprised of two in-
verted repeats wherein each repeat is composed of 5 TMHs. Interestingly,
although sharing a low sequence homology, this fold is also observed in
other sodium symporters such as the sodium leucine symporter (LeuT) [68]
and the sodium benzyl-hydantoin symporter (Mhp1) [69].
The aim of my studies was to provide structural insight on the enzymes
involved in the catabolic pathway and the corresponding sialic acid trans-
porters that are essential for the import of sialic acid into the cytoplasm.
The bulk of this thesis describes the production and crystallization strate-
gies aimed for structure determination of the enzymes and transporters in
the sialic acid catabolic pathways. Further, crystal structures of a Nan ki-
nase in the catabolic pathway and a sialic acid transporter from the soldium
solute symporter (SSS) family are presented.
1.11 Scope of this thesis
This thesis presents the construct screening, expression, purification, crys-
tallization and structure determination of enzymes and trasnporters involved
in the sialic acid catabolic pathway. Chapter 2 introduces the X-ray crystal-
logaphy methodology. In Chapter 3, Paper 1 and Paper 2 will be discussed.
In Chapter 4, the entire pipeline of membrane protein crystallization from
detergent screening to crystallization is taken into account, summarizing
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Paper 3. Chapter 5 discusses the crystal structure of the first sialic acid
transporter, described in detail in Paper 4. Finally, Chapter 6 discusses the
conclusion and future perspective.
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Chapter 2
X-ray Crystallography
X-ray crystallography remains the most widely-used technique in struc-
tural biology. Since the determination of myoglobin structure in 1957 [70]
crystal structures continue to advance our understanding of the biological
processes of life. X-ray snapshots of these molecules of life in atomic detail
have facilitated the development of medicine through structure-based drug
design. The increasing number of protein structures being determined has
established X-ray crystallography as a reliable and accessible technique.
This chapter presents the methodology in X-ray crystallography, a tech-
nique used to obtain the three-dimensional molecular structure from a crys-
tal.
2.1 What is in a crystal?
When molecules in solution come together and self- assemble into a highly
ordered and periodic manner, a crystal is formed. An asymmetric unit is the
smallest building block of a unit cell. For chiral macromolecules like pro-
teins, there are 65 combinations of rotational and translational symmetry
that can be applied to the asymmetric unit for reconstructing the entire unit
cell. The number is limited to 65 out of 230 space groups because of the chi-
rality of the proteins. Some combinations of symmetry operations such as
mirror images and inversions are not possible since they do not generate an
identical copy of the molecule but instead change the molecule’s handed-
ness.
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2.2 No crystal, no x-ray crystallography
For a crystal grower, the path to a single and well-defined crystal is never
trivial. Moreover, a crystal grower has to devise a systematic approach or
else the time required to test all parameters is not feasible. Knowledge of
the intrinsic properties of the desired protein, a good grip of the basic prin-
ciple of crystallization and recognizing the caveats of the available statistics
to be tested are important in crystallization. At some point during crystal-
lization trials, a crystal grower has to make a decision whether to continue
pursuing yet another crystallization condition or to abandon the construct
and take up a new one.
Crystal formation is possible because well-ordered protein molecules
self-assemble periodically. This formation entails conformational homogene-
ity so that units can stack side by side in highest order possible. The inter-
molecular forces that hold these protein molecules are specific and weak,
owing to the proteins flexibility and are thereby easily broken. These inter-
molecular interactions are made up of low binding energies such as hydro-
gen bonds, van der Waal contacts, salt bridges and hydrophobic interac-
tions. In between this weak and specific network of intermolecular interac-
tions are large gaps of solvent channels that serve as the medium for small
molecules to migrate and bind to active sites and heavy atoms that reach
and bind the molecules during soaking.
2.3 The crystallization diagram explained
The purpose of a crystallization experiment is to reduce the protein sol-
ubility in the solution to the point that phase separation occurs. First, a
protein-rich phase is formed that is supersaturated then a nucleation event
triggers the molecules to self-assemble into a well-ordered crystal lattice.
The crystallization diagram is separated into three regions; called the
stable, metastable and unstable. Within the stable region, the solution is in
a single phase and the protein molecules are spread out and hardly mak-
ing contact with each other. The protein molecules are surrounded by the
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solvent (water and precipitant). As the protein solubility decreases, the sol-
ubility line is crossed and the phase transitions into the metastable region.
Within this region, the solution becomes supersaturated and a protein-rich
phase is formed. Here, collisions and contacts between protein molecules
are more frequent. However, the metastable region is subdivided into two
zones; heterogeneous nucleation zone and homogeneous nucleation zone. In the
heterogenous nucleation zone, nuclei sites are difficult to form but can grow
on externally introduced nuclei. Few protein molecules gather momentar-
ily together and then eventually dispersed. Whereas in the homogenous
nucleation zone, the solution is supersaturated enough to spontaneously
induce nucleation sites. After nuclei form, the molecules move towards the
nucleation zone for slower crystal growth that yields better crystals[71].
More often than not, microcrystal showers appear in the drop. This hap-
pens when supersaturation is nearly approaching the unstable phase. Here,
multiple nuclei sites are formed and upon induction of many nuclei, the
supply of protein molecules becomes limited and growth becomes stunted.
These microcrystals could be seeded into fresh drops (Figure 2.1).
2.4 Growing crystals by vapor-diffusion
There are various crystallization techniques that can be employed to grow
crystals. The one used in this thesis is the vapor-diffusion technique, both
the hanging-drop and sitting drop versions. The hanging drop method is
used for manual setups while the sitting drop method is more suited and
optimized for robotic setups. The hanging drop method typically uses a 24-
well Linbro plate or another plate with similar caliber, equal amounts (typ-
ical volume of 1 µl) of protein solution and reservoir solution are mixed
on a siliconized cover slide and the cover slide is flipped over to seal the
greased-rim well containing the mother liquor. In this closed system, the
water diffuses from the protein-reservoir hanging drop into the reservoir,
since the reservoir has double the concentration compared to the drop. As
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Figure 2.1: The crystallization diagram is divided into three regions; the sta-
ble, metastable and the unstable. The heterogenous nucleation zone and
homogenous zones nucleation zone subdivided the metastable region.The
open small circles are water molecules while the closed small circles are pre-
cipitant molecules.
the water vapor diffuses out of the drop, the protein and precipitant con-
centration increases in the drop and phase separation takes place. Because
of supersaturation, nucleation is induced and crystals may form [71, 72].
The sitting drop method applies the same principle in a closed system
but the drop is placed in a shelf slightly elevated from the mother reservoir.
This method is optimized for automation using a 96-well plate (Figure 2.2).
In Paper 2 and Paper 3, sparse matrix screening kits for soluble and
membrane proteins were initially used to sample the crystallization condi-
tions that are known to drive crystal formation. Grid screens were set up for
both proteins wherein the concentrations of salt, polyethylene glycol PEG
and their pH were varied. In addition, additive screens were used for Paper
3 to improve the diffraction quality of the crystals.
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Figure 2.2: Two methods of vapor diffusion: The hanging drop method (left)
and the sitting drop method (right). The closed system wherein water dif-
fuses from the drop into the reservoir
2.5 Cryocooling and cryoprotection
Once a crystal is formed, the next step is to harvest the crystal from the
mother liquor. This is done by scooping or fishing the crystal with a nylon
loop and immediately plunging it into the liquid nitrogen to be flash cooled.
Cryocooling the crystals reduces the severity of the radiation damage caused
from the exposure of the ionizing X-ray radiation. However, cooling down
the crystals to cryogenic temperatures also often causes the mother liquor
surrounding the crystal to form crystalline ice. The presence of ice around
and inside the crystal greatly diminishes the diffraction quality of the crys-
tal. To prevent this from happening, cryoprotecting the crystal has become
vital during harvesting. To cryoprotect the crystal, it is carefully dipped
into the cryoprotectant immediately before flash cooling.
There are a variety of cryoprotectants that can be used, the most com-
mon ones are low molecular glycerol, PEG, ethylene glycol and sucrose
which could be mixed in a buffer. In Paper 2 and Paper 3, 10 % of glycerol is
mixed with the mother liquor as cryoprotectant and crystals was carefully
dipped before flash cooling.
26 Chapter 2. X-ray Crystallography
2.6 Diffraction of X-rays by a crystal
X-rays are high energy electromagnetic radiation. As they pass through a
crystal, they scatter on the electrons of the atoms. If the resulting scattered
waves superimpose in phase, the waves get amplified producing construc-
tive interference. The scattering from a single molecule is very weak and
very hard to detect. However in a crystal lattice, because of the periodic
arrangement of the molecules, the total scattering intensities are amplified
due to constructive interference. Bragg’s law describes the conditions nec-
essary for the emanating waves to interfere constructively and give max-
imum diffraction. Bragg’s law predicts the reflection of X-rays on the set
of lattice planes hkl, as a function of the diffraction angle θ and the lattice
spacing d and X-ray wavelength λ if
2dsinθ = nλ (2.1)
where n is an integer.
2.7 The diffraction geometry
The basic idea of a diffraction experiment is that there is a source of X-rays,
a rotating device for the crystal (goniostat) and an X-ray detector placed
behind the crystal to record the intensities of the incoming reflections. How
does this setup correlate to the diffraction condition? In 1921, Paul Ewald
applied the Bragg’s law (diffraction condition) into the diffraction geometry
in a diffraction experiment as a way of sampling the reciprocal space.
The scattering vector Shkl from the indices h,k,l of crystal planes in real
space corresponds to the reciprocal space vector d∗hkl that are both perpen-
dicular to the reflecting planes. On an Ewald construction, given with a
sphere radius of 1/λ, the relationship of the reciprocal lattice vector to the
reflection condition is described by the equation d∗hkl =
1
dhkl
= 2sinθnλ . There-
fore, d∗hkl = S =
2sinθ
λ , diffraction occurs if the S vector is collinear and has
equal radius with the reciprocal space vector d∗hkl . This is what happens
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Figure 2.3: The Ewald construction applies the Bragg’s law into the diffrac-
tion geometry in a diffraction experiment as a way of sampling the reciprocal
space.(Adapted from Rupp [71])
when the reciprocal lattice point h,k,l lies on the Ewald sphere (Figure 2.3).
Only a fraction of reciprocal lattice points lie on the Ewald sphere. At any
given crystal orientation, by incrementally rotating the crystal, this brings
other lattice points onto the Ewald sphere, thereby sampling more lattice
points and yielding more diffraction spots.
2.8 Data collection
A space group has to be identified so that each recorded reflection is la-
belled with (at least) one Miller index (indexing step). Since the lattice sym-
metry is often unknown, the pattern of their diffraction vectors is used to
rationalize the potential candidates (autoindexing). By integrating the in-
dexed spots, the total intensity of the reflection is calculated. Indexing and
integrating can be done with programs like MOSFLM [73] and XDS. In data
reduction, program SCALA [74] or Aimless [75], scales the intensities of
equivalent reflections and merges partial observations to full and finally
merges symmetry equivalent observations together.
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2.9 The structure factor and B-factor
During a diffraction experiment, an X-ray detector measures the photon
count at a given position. The intensity of the signal or the number of
photons in each reflection is determined by the molecules in the real space
crystal lattice. The measured intensity of each reflection with Miller indices
h,k,l is directly correlated to the magnitude of the structure factor ampli-
tude. Hence, “the structure factor is the summation of the individual scat-
tering contributions of each and every atom” [71]. It also a complex vector
with amplitude and phase information. However, the phase information is
lost during the detection process, giving rise to the phase problem in X-ray
crystallography. The phase information is very crucial in the reconstruction
of the electron density by Fourier Transform of the x-ray scattering ampli-
tudes.
As it happens, the mean positions of the atoms are disrupted due to
thermal vibration and other type of displacements. Displacement of the
atoms attenuates the scattering contribution of the atoms, resulting in poor
diffraction intensity. Higher diffraction angles are more affected by atomic
displacements and crystals with high disorder limit the crystallographic
resolution (dmax). The extent to which the atoms are displaced also sig-
nifies the degree of disorder in the crystal lattice. Attenuated scattering in
this scenario is measured by the isotropic displacement parameter or the B-
factor. Usually the B-factor is inversely correlated to the occupancy of the
atom. If the B-factor is high, this could mean that the diminished scattering
contribution is due to less than full occupancy of the atom.
2.10 The electron density reconstruction
A Fourier transform converts a list complex structure factors (reciprocal
space) to the electron density (real space) of the scattering molecule. In
the reconstruction of the electron density, there are two Fourier coefficients
that are essential; the structure factor amplitude and the phases.
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ρ(x, y, z) =
1
V
−h
∑
h
−k
∑
k
−l
∑
l
Fhkl · exp[−2pii(hx + ky + lz− αhkl)] (2.2)
The structure factor amplitude is proportional to the square root of the
measured intensity that is obtained during the diffraction experiment while
the phases come from external sources such as experimental phasing or
from a structurally similar protein.
2.11 The Patterson function
Unlike the electron density map that needs both the structure factor am-
plitudes and the phases to be reconstructed, the Patterson map can be di-
rectly computed solely from the observed intensities. The map describes
the interatomic distance vector uvw between atoms. The value of the Pat-
terson function during its application in acquiring the missing phase infor-
mation, cannot be overstated. The Patterson map is useful in determining
the marker atom in both isomorphous and anomalous difference data and
finding out the orientation of the search model in a unit cell for molecular
replacement.
P(u, v, w) =
1
V ∑h
∑
k
∑
l
F2h cos2pi(hu + kv + lw) (2.3)
2.12 The phase problem
In experimental phasing, acquisition of the phases relies on the difference in-
tensity between data sets of the heavy or anomalous marker atoms. Sin-
gle isomorphous replacement (SIR) and multiple isomorphous replacement
(MIR) methods require derivative crystals soaked with heavy atoms. The
intensity difference between the derivative crystal data and native crystal
data is compared. In anomalous diffraction methods from crystals contain-
ing anomalous scatters, single-wavelength anomalous diffraction (SAD) and
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multiple-wavelength anomalous diffraction (MAD), uses anomalous differ-
ence and dispersive difference data measured at different wavelengths re-
spectively. Both difference methods require isomorphism when multiple
crystals are used.
If there is a known structure that is similar to the sought-after protein
structure, molecular replacement is the most common phasing method that
is used. The method may work with as low as ∼ 30% sequence homol-
ogy. Initially, the orientation of the search model is determined by applying
three-dimension cross rotation search using a Patterson function. This is
followed by probing the actual location of the search model in the unit cell
through a translational search. Programs commonly used for molecular re-
placement are PHASER [76] and Molrep [77].
In reconstructing the electron density, it is the phase of the structure
factor that holds most of the structural information. In obtaining the phases
through molecular replacement, phase bias is an inherent problem, because
the starting electron density map will be highly biased towards the search
model.
2.13 Model building and refinement
Model building and refinement consists of alternating rounds of building
the structural model by fitting it into the electron density in real space and
by fixing geometric error in restrained reciprocal space refinement. The
process is iterative: one goes back to the model building and guided by
improved electron density maps and then refine again.The idea is as this
process is cycled several times, the maps progressively improve and the fi-
nal molecular structure describe the experimental data well and the spatial
distribution of atoms make chemical and physical sense. COOT [78] is the
computer graphic that used is in model building while refinement is often
carried out by REFMAC [79].
Difference maps are used to aid in interpreting the electron density and
minimizing the model bias. Difference maps are generated from different
combinations of the Fourier coefficients. To generate the difference map,
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(Fo − Fc) · exp(iφc), the Fourier coefficients used are the observed structure
factors from the measured intensity Fo and the calculated Fc structure fac-
tors from the model, the phases φc is also calculated from the model. The
negative density region in the (Fo − Fc) · exp(iφc) map indicate where the
density should not be present while the positive density regions indicate
where there is a missing electron density. The (2Fo − Fc) · exp(iφc) map is
more suitable for the initial model building as the positive density signal is
strengthened.
To assess the overall fit between the observed data and the model, the
linear residual or the R-value is calculated. This uses the Fobs which is the
structure factor amplitude from the measured intensity and the Fcalc , the
calculated structure factor amplitude from the model:
R =
∑
h
|Fobs − Fcalc|
∑
h
Fobs
(2.4)
During the course of the structural refinement, the R-value decreases
as the fit between the observed structure factor amplitudes (the diffraction
experiment) and computed structure factor amplitudes (the model) is im-
proved.
2.14 Cross validation
As the parameters are adjusted during the refinement, the model improves
and the R-values decreases. However, overparameterization is a real risk
in reciprocal space refinement and the R-value will not indicate a problem.
Specifically, adding unnecessary parameters to the reciprocal space refine-
ment, results in a dropping R-value. To act as a restraint for R-value, Axel
Brunger introduced cross validation in the form of ’R-free’ [80].
The idea is by setting aside ∼ 5% of the reflections from the experi-
mental data and excluding them from the refinement, a comparison can be
judged between how well the model fits with the excluded ‘test data set’
which is ’R-free’ and how well the model fits with the working data set,
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which is R-work. How ’R-free’ and R-work follow each other is monitored
during successive model rebuilding and refinement steps. If parameters are
unnecessarily added that results in no physical improvement on the model,
’R-free’ will stop improving and may even increase whereas the R-work
value will still continue to drop. Too wide a gap between R-free and R-
work is an indication for overfitting and the accuracy of the model is com-
promised, whereas too close ’R-free’ and R-work is an indicator that more
parameters can still be introduced to improve the model.
While ’R-free’ can serve as a cross validation in reciprocal space [80],
omit maps can provide a cross validation in real space. As the name sug-
gests, omit maps are generated by omitting the structural model around
questionable region from the density calculation and scrutinizing if the
problematic region is still present in the omit map.
Structural validation is the next step when refinement reaches conver-
gence. The program MolProbity [81] generates an error report of the struc-
tural model. After checking the geometry of the backbone torsion angles φ
and ψ and clearing the structure for Ramachandran outliers, the polished
structure is now ready for biological interpretation. Depositing the newly
determined structure to the Protein Data Bank (PDB) also provides an addi-
tional validation report.
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Fn N-acetylmannosamine kinase
In Paper I, we describe a complete automated method of optimizing the
cloning, expression and purification of eighteen enzymes [82]. These en-
zymes are orthologues from the nan-nag gene cluster regulating the sialic
acid catabolic and surface sialylation pathways from the pathogens Vib-
rio cholera, Pasteurella multocida, Fusobacterium nucleatum and Haemophilus
influenzae. These studies aim to develop a less time-consuming, efficient
and cost-effective method of screening wide-ranging multiple constructs
for production of functional recombinant proteins to be used in crystallo-
graphic studies and functional assays. Results for the expression and solu-
bility tests conducted for FnNanK from this paper are applied for the crys-
tallization and structure determination of FnNanK described in Paper 2.
3.1 Automated cloning
We implemented an automated cloning strategy for preparing the constructs
for optimization in expression and purification of the sialic acid catabolic
and sialylation pathways enzymes. For efficient and quick dispensing of
liquids, a Liquid Handling System was used during the entire automation
process. The desired gene flanked by the 15bp attB sites to be cloned into
the Gateway vector pET300/NT-DEST was PCR amplified using a thermo-
cycler in 96-well plates. The Gateway cloning technology [83] allows the
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efficient transfer of DNA sequences into multiple vectors without the sub-
cloning steps involving restriction enzymes. After generating the entry vec-
tor comprising the gene of interest and a cloning vector engineered with
lambda phage recombination sites, it is convenient to transfer the gene of
interest into multiple vectors for expression or functional studies. The con-
structs were transformed into competent Dh5α cells in a 96-well plate and
after incubation the reaction mixture was plated onto a 6-well plate with
LB Agar. Distinct colonies were isolated for plasmid amplification and se-
quencing (Figure 3.1).
3.2 Expression and media optimization
After confirmation by sequencing, all 18 constructs were transformed into
three different E.coli expression strains namely BL21(DE3), BL21(DE3)PLysS
and Rosetta 2. Subsequently, colonies that grew after the transformation
were selected by an automated colony picker and inoculated into two dif-
ferent culture media, 2x YT and ZYM media for seed culture. Overnight
seed cultures were transferred into 24-well plates with 2x YT or ZYM me-
dia for expression screen. The plate containing ZYM autoinduction media
[84] yielded optimal expression of the constructs whereas the 2x YT media
plate has very low to no expression. This is largely because of the varying
time for each construct to reach the optimal optical density. Generalized
IPTG induction may have affected the expression quality of each protein.
Afterwards, the cell pellets were normalized and lysed using Bacterial
Protein Extraction Reagent (BPER) and transferred into a 96-well plate. The
expression and solubility of each construct was analyzed by running the
total lysate and the soluble fractions on Caliper Gx (Figure 3.1). Of the 18
constructs, 11 yielded soluble protein expression. The E. coli BL21(DE3)
strain is the most successful for 9 of the 11 constructs while 4 and 3 con-
structs gave soluble expression for BL21 (DE3) PLysS and Rosetta (DE3)
respectively.
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3.3 Purification and scaling up
Viable constructs for overexpression were purified using Ni-NTA-based 96-
well filter plates and load, flow through and elutes fractions were collected
separately and analyzed by running them on Caliper GXII system. De-
riving from the automated optimization screening, the large scale produc-
tion and purification of constructs FnNanA, FnNanE, FnNanK, HiNanK,
followed by crystallization yielded crystals. The automated pipeline of
cloning, expression and purification described here is efficient and cost-
effective. Production of proteins suited for structural studies usually starts
with screening of a broad base of constructs. Along the way, bottlenecks are
encountered and these problems are circumvented in a trial and error pro-
cess. Streamlining the screening for the optimal conditions for expression,
solubility and purification of several constructs in 96-well plates, facilitates
the identification of viable constructs. Further automation optimizes condi-
tions that therefore yield successful purification with minimal manual inter-
vention. Unlike previous automated pipelines [85, 86], Paper 1 describes an
integrated pipeline with absolute minimal manual intervention in cloning,
expression and purification.
The successful large scale purification of FnNanK was based on the au-
tomated small scale screening for optimal expression and purification of 18
sialic acid catabolic and sialylation enzymes from Paper 1. The crystalliza-
tion and the ensuing structure determination of FnNanK was facilitated by
the automated process.
3.4 Fn N-acetylmannosamine kinase crystal
structure
Fusobacterium nucleatum (Fn) N-acetylmannosamine kinase (NanK) catalyzes
the transfer of a phosphoryl group from ATP to C6 of ManNAc yielding
ManNAc-6-P in a degradation pathway that ultimately breaks down sialic
acid to fructose-6-P and thereby entering glycolysis (Figure 3.2).
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Figure 3.1: Flow charts for automated cloning (A), expression(B) and purifi-
cation (C) on the liquid handling system.The entire pipeline is automated
with the most minimal manual intervention (Reproduced from Bairy et al
[82].)
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Figure 3.2: The second step in bacterial sialic acid catabolic pathway; N-
acetylmannosamine kinase phosphorylates ManNAc to ManNAc-6-P. (Fig-
ure reproduced with permission of the International Union of Crystallogra-
phy. [87])
In Paper 2, the apo crystal structure of FnNanK was determined at 2.23
Å in resolution and structurally aligned with other bacterial Nan kinases
available in Protein Data Bank PDB [87]. FnNanK structural alignment with
the human N-acetylmannosamine kinase domain of the bifunctional UDP-
N-acetylglucosamine 2-epimerase / N-acetylmannosamine kinase (hMNK)
[88], the only crystal structure of nan kinase bound with both ManNAc and
ATP and well-characterized, provided insight into the putative active site
of FnNanK.
3.5 The ROK superfamily
FnNanK belongs to the repressor, open reading frame kinase (ROK)[89] su-
perfamily which largely consists of transcriptional repressors, sugar kinases
and other unknown gene clusters. Members of the ROK family share sig-
nature features such as: (i) nucleotide-binding site with a DxGxT consen-
sus sequence on the N-terminal region; (ii) a highly conserved aspartate
within the active site loop; (iii) an ExGH motif that interact with the sugar
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substrate; (iv) and a zinc-binding motif with the consensus sequence Cx-
CGxxGCx(E/D) [90]. Zinc-binding is believed to have an integral role for
upholding the structural stability in the active site.
3.6 Protein production, purification and
crystallization
FnNanK was overexpressed and purified using immobilized metal affinity
and size exclusion chromatography. The homogeneity of the collected frac-
tions were analyzed through SDS PAGE. The collected fractions were con-
centrated to 14 mg/ml which was then used for the ensuing crystallization
trials. Within one week, rod-shaped crystals formed under reservoir condi-
tions of 0.2 M Lithium sulfate monohydrate, 0.1 M Tris-HCl pH 8.5 and 30%
(w/v) PEG 4000 through sitting drop vapor diffusion method. The crystal
diffracted to 2.2Å and the structure was solved by molecular replacement.
3.7 FnNanK overall crystal structure
FnNanK has a homodimeric structure resembling a butterfly [87] (Figure 3.3).
Each V-shaped monomer contains 11 alpha helices and 11 beta-sheets with
alpha/beta domains and an inner cavity. The domains are held together
by hinge loops. Each protomer consists of an N-terminal domain and a
C-terminal dimerization domain. The N-terminal domain begins from the
N-terminus until residue 118 then proceeded from residue 272 ending to-
wards the C-teminus. The C-dimerization domain is from residue 126-268
(Figure 3.4). Within the cavity of the V-shaped monomer, situated between
the N-terminal and C-terminal dimerization interfaces, is the putative bind-
ing site of the substrate ManNAc (Figure 3.3).
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Figure 3.3: The homodimeric structure of FnNanK determined at 2.2 Å in
resolution.(Reproduced with permission of the International Union of Crys-
tallography. [87])
3.8 The putative binding site
Superimposition of the FnNanK structure with the ligand-bound human
NanK (hMNK; 2yhy PDB) shows high similarity in the overall fold with a
root mean square (r.m.s.) deviation of 2.5 Å, alignment length of 280 Cα
atoms and 23% sequence identity. The highly conserved residues in hu-
man NanK (Asn516, Asp517, Arg477, Glu566, His569 and Glu588) that are
required for the coordination of ManNAc are superimposable with corre-
sponding residues (Asn106, Asp107, Gln67, Glu156, His159 and Glu168) in
FnNanK.
Further structural alignment of the residues in the putative binding site
region with two other bacterial Nan kinases, E.coli NanK (EcNanK; 2aa4)
and L. monocytogenes NanK (LmNanK; 4htl) shows that they are superim-
posable with the r.s.m.d of 2.6 Å and 1.9 Å, respectively. EcNanK residues
(Asn104, Asp105, Ile66, His153, His156 and Glu 175) and LmNanK residues
(Asn102, Asp103, Tyr64, Glu152, Tyr155 and Asn172) which are involved in
the substrate binding are superimposable to the putative binding site region
40 Chapter 3. Fn N-acetylmannosamine kinase
Figure 3.4: Each monomeric structure of FnNanK consists of N-terminal do-
main (blue) and C- terminal dimerization domain (pink).(Reproduced with
permission of the International Union of Crystallography. [87])
of FnNanK (Figure 3.5).
3.9 Lack of the zinc-binding site
FnNanK lacks the zinc-binding motif that is considered to be a shared fea-
ture of the members of the ROK superfamily. The consensus sequence Cx-
CGxxGCx denoting the zinc-binding region is absent in FnNank, while the
site is eliminated by substitution in LmNanK . His159 in FnNanK is highly
conserved corresponding to residues His156 in EcNanK and His569 in hu-
man NanK. In hMNK structure [88], this highly conserved histidine residue
is coordinated to both the zinc ion and the substrate ManNAc. Both the
corresponding strictly conserved histidines in hMNK and EcNank are no-
tably shifted compared to the uncoordinated histidine His159 in FnNanK.
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Figure 3.5: The lack of zinc-binding site. Structural alignment of FnNank
with E. coli NanK and L.monocytogenes NanK.(Reproduced with permission
of the International Union of Crystallography. [87])
Instead of three cysteines that supposedly coordinate with the zinc ion, a
glutamate residue is present in FnNanK (Figure 3.5).
More than being a signature feature of the ROK superfamily, the zinc-
binding motif is implicated in upholding the structural integrity of the ac-
tive site. Studies in cysteine deletion mutagenesis in the cysteine-rich re-
gion in the zinc-binding site exhibit inactivation of the B. sublitis glucoki-
nase [91]. As observed in the hMNK structure, the zinc ion coordinates with
three cysteines and the strictly conserved histidine residue His569, which in
turn coordinates with the substrate in the active site, linking the zinc-motif
region to the ManNAc binding site. Mutating two cysteines associated in
the zinc-binding in E.coli Mlc repressor, compromised its repressor function
[92]. Despite of the absence of the zinc-binding region in FnNanK, all its
major structural features are still conserved. To gain insight into the confor-
mational change that takes place upon binding of a substrate, an FnNanK
structure bound ManNAc and ATP analogues is required.
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3.10 Summary
Automation of the process of optimizing cloning, expression and purifica-
tion ofthe 18 enzymes associated to the sialic acid degradation and surface
sialylation paved the way for finding optimal conditions for the subsequent
large scale production, purification and crystallization of these enzymes.
One of them was FnNanK.
The FnNanK crystal structure shares structural motifs characteristic of
the ROK family. One of these motifs is the presence of a zinc binding site
which is known to be important for structural architecture in homologous
enzymes. This motif however, is notably absent in FnNanK. Even though
FnNanK lacks the zinc-binding region, its main structural features are well
preserved.
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Sialic Acid TRAP Transporters
Embedded within the lipidic bilayer of the cellular membrane, membrane
proteins have an integral role in numerous biological processes. They serve
as receptors, channels and transporters. Their crucial functions in many cel-
lular processes make them a major drug discovery target. Structural infor-
mation provides valuable insight to important mechanisms guiding drug
development.
In 1985, the photosynthetic reaction center of Rhodopseudomonas viridis
was the first membrane protein structure to be determined by x-ray crys-
tallography [93]. Since then, 827 unique membrane protein structures have
been solved [94]. Nevertheless, the first membrane protein structure deter-
mined for heterologous expression, the potassium channel KcsA [95] was
elucidated more than a decade after R. viridis photosynthetic reaction cen-
ter. However the growth of membrane protein structure determination was
not exponential. Membrane protein structure determination lags behind
soluble proteins [96].
The onset of heterologous expression systems used for high yielding
overexpression of recombinant protein; development of new detergents for
improved protein solubility and crystallizability; and recent technological
advancements in synchrotron and beamlines, are all factors that greatly
contributed to the steady growth of membrane protein structure entries in
Protein Data Bank [97–99].
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Figure 4.1: Workflow of the production and purification of membrane pro-
tein aimed for structural studies.
Despite this progress, the path to membrane protein structure determi-
nation is paved with obstacles and bottlenecks. Membrane protein produc-
tion and crystallization remain an empirical process (Figure 4.1). In this
chapter, the methodology of membrane protein production, solubilization,
purification and crystallization is introduced. In the same vein, the entire
pipeline of sialic acid TRAP transporters crystallizability in Paper 3 will be
discussed.
4.1 Construct design and expression system
Once the decision to use Escherichia coli as the host organism is taken, the
entire pipeline of membrane protein production to purification can be out-
lined. Of the bacterial expression systems, E. coli is often the preferred
host for heterologous membrane protein overexpression. Its advantages are
short generation time, tolerance of high cell density, it is inexpensive and
suitable for transformation by exogenous DNA and the wild-type E. coli
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strains are modified into a variety of expression strains that are designed
for different expression system [100, 101].
In Paper 3, we used the araBAD and T7 expression systems, which are
inducible by arabinose and IPTG respectively. Four orthologues of the sialic
acid TRAP transporter were cloned into pBad and pWarf vectors for regu-
lated production of the desired recombinant protein. It is established that
heterologous recombinant membrane protein expression is considered toxic
for the bacterial host cells [102, 103]. Unchecked expression of the recombi-
nant membrane protein saturates the cellular capacity of the host and over-
loads the Sec translocase pathway. The accumulation of protein triggers cell
stress response that impede cell growth and even cause cell death [104].
Control of expression is the key in recombinant membrane protein pro-
duction. Quantity does not necessarily entail good quality, stable and prop-
erly folded membrane proteins. For this purpose, a low copy vector such as
pBad [105] and pWarf [106] are suitable for membrane protein expression.
Their tightly regulated and finely tunable systems are designed to circum-
vent the problems of misfolding and aggregation resulting in the formation
of inclusion bodies.
As described in Paper 3, the araBAD expression system yielded better
results for PmTRAP compared to the T7 expression system. Although both
systems can be regulated, the mechanisms employed are distinct. The T7
expression system [107] is known to suffer from leaky expression, because
the lacUV5 promoter that transcribes T7 RNA polymerase is not completely
shut off by LacI [108, 109]. Thus, there is a steady pool of T7 RNA poly-
merase being transcribed and this subsequently leads to basal expression
of the recombinant protein that is toxic to the host cells.
To reduce leaky expression of the T7 expression system, we used the
Lemo21(DE3) strain [110] that counteracts the low level expression of T7
RNA polymerase with T7 lysozyme, a known T7 RNA polymerase inhibitor.
Expression of the T7 Lys is controlled by the rhaBAD promoter, which is
inducible by L-rhamnose. In practice, the amount of L-rhamnose is opti-
mized in order to increase the yield of the recombinant protein during test
expression. For Pm TRAP the yield was still poor, despite this optimization
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procedure (Figure 4.2a).
Compared to the T7 expression system, the araBAD system is a pos-
itively controlled expression system. Adjacent to araBAD operon, AraC
functions both as the activator/repressor on the araBAD promoter. In the
absence of an arabinose inducer, araC binds to two sites on the operon form-
ing a loop that hinders RNA polymerase from binding to the promoter.
Upon binding to the inducer, the loop is relaxed as both araC and CAP
function as activators by promoting the binding of RNA polymerase to the
promoter.
Temperature affects protein overexpression. Lowering the temperature
slows down the rate of protein production thereby giving the Sec translo-
case machinery ample time to fold the recombinant membrane protein prop-
erly and thereby prevent the saturation of the signal recognition particle
(SRP) pathway. The optimal temperature for membrane protein produc-
tion is reported to be 20-30 oC [111]. In Paper 3, we lowered the incubation
temperature from 30 oC to 21 oC after induction for an 18 h culture for better
yield.
4.2 Detergent and solubilization
Like lipids, detergents are amphiphatic and possess a hydrophilic head-
group and a hydrophobic tail. Detergents are used to extract membrane
proteins from their natural lipidic environment and shield the hydrophobic
regions of membrane proteins. The protein becomes soluble in the aqueous
media, and in optimal cases, with its native conformation intact [112]. If
the hydrophobic transmembrane regions are not shielded this may lead to
aggregation of membrane proteins.
At low concentrations, detergents are present as monomers. When the
detergent concentration reaches a critical point, the detergent monomers
form spherical micelle structures as the hydrophobic tails associate in the
core of the micelle and the hydrophilic head groups form hydrogen bonds
with water. The minimal detergent concentration required for detergent
monomers to form micelles is known as the critical micellar concentration
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Figure 4.2: TRAP transporters expression and detergent screening. A.
pWarf(+) constructs in-gel flourescence to assess levels of expression. The
feature at 41 kDa is an artefact. B. Whole cell relative flourescence unit (RFU)
for pWarf(+)constructs for Fn, Hi, and Vc detergent screen. C. Vc and PM
pBad constructs manual detergent screen after 4 h and overnight treatment
of different detergents.
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Figure 4.3: Detergent phase diagrams. Phase separation from two types
of detergents. A. Phase separation of nonionic detergents has lower con-
sulate boundary (line separating micelle solution and phase separation). B.
Phase separation in zwitterionic detergents and glycosidic detergents [103].
(Adapted from Linke [112].)
(CMC) and the minimum temperature above which a micelle can form is
called the Kraft temperature. Another important aspect of detergents is the
size of the micelle, which is determined by the average number of deter-
gent monomers forming the micelle. Detergents undergo phase separation
induced at a certain temperature (cloud point) wherein the solution sep-
arates into detergent-poor and detergent-rich phase [112–114]. In deter-
gent rich phase, immiscible non-micellar aggregates assemble which can be
problematic during crystallization. The phase behavior of the detergent
is largely dependent on the physicochemical properties of the detergent
together with the ionic strength and the pH conditions of the buffer (Fig-
ure 4.3).
The classes of detergents are determined according to their head group
charge. Ionic detergents are harsh detergents carrying either anionic or cationic
group charge. This class of detergent disrupts not only the lipid-lipid and
lipid-protein bonds but also the protein-protein bond. Non-ionic detergents
have uncharged head groups making them a mild and gentle detergent.
Not surprisingly, this class of detergent is routinely used for membrane
protein extraction. The sugar based maltoside and glucoside are the most
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prevalent ones. The zwitterionic detergents carry the combined properties of
ionic and non-ionic detergents. They are harsher than non-ionic detergent,
but not as aggressive as the ionic detergents. Zwitterionic detergents like
Fos-choline are capable of disrupting the lipid bilayer, while retaining the
proteins native conformation [115, 116].
Solubilization of membrane proteins starts at lower concentration of the
detergents, when they penetrate into the membrane bilayer and disrupt it.
As the detergent concentration increases, the lipid bilayer disintegrates and
the hydrophobic tails of the detergent enwrap the hydrophobic transmem-
brane region of the embedded protein forming the protein-detergent-lipid
complex. This process stabilize membrane proteins in an aqueous solution
(Figure 4.4). Harsher detergent treatment leads to delipidation of the protein-
detergent-lipid complex and removal of the essential lipids can destabilize
the structure of membrane proteins.
If after extensive ultracentrifugation of the detergent incubated mem-
brane, the membrane protein remains in the supernatant, it indicates that
the solubilization was successful. In Paper 3, multiple detergent solubi-
lization protocols were tested on TRAP transporter orthologues. These or-
thologues were fused to green fluorescent protein (GFP)[117–119] and pro-
duced in T7 expression systems. The fused GFP protein allows one to keep
track of the expressed protein during the solubilization process. For the
araBAD expression system, the orthologues were tagged with 6x His in the
N-terminal region. A conventional detergent screen was applied and the
membrane protein purified.
The expression levels of Vc, Hi and Fn TRAP transporters expressed
in pWarf system were quantified by measuring relative fluorescence units
(RFU) of the whole cell, the supernatant and pelleted fractions. The analysis
was repeated with six different detergents. The amount of solubilized Fn
TRAP was similar for all detergents, except MNG-10. Hi TRAP was solu-
bilized best using β-OG, while Vc TRAP was soluble in all tested detergent
with the exception of Fos-Choline (Figure 4.2b).
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Figure 4.4: Membrane protein solubilization. A. Detergent monomer. B.
Detergent in micellar formation. C. At low concentration the detergent dis-
rupts the membrane bilayer. D. With increasing detergent concentration the
detergents wraps around the transmembrane hydrophobic region forming
the protein-detergent-lipid complex.
Another way to characterize the solubility of the membrane protein in-
cubated in different detergents is through Western Blot analysis. The inten-
sity of the bands corresponds to the amount of membrane protein solubi-
lized after detergent treatment. Pm and Vc TRAP transporters produced
via pBad vector were detergent-treated with the membrane fractions (M)
before centrifugation and the supernatant fraction (S) after centrifugation
compared through Western Blot analysis. For Vc TRAP, 2 h of solubilization
shows bands from the supernatant fraction with membranes treated with
DM, β-OG, MNG and LDAO. On the other hand after overnight solubiliza-
tion, the protein was only stable in DM and MNG detergents. Furthermore,
the 2 h treatment with DM and β-OG made a small fraction of Pm TRAP
soluble, and solubilzation with MNG was more successful. Longer incu-
bation improved the solubilization yield with detergents DM, MNG and
β-OG and LDAO showed also showing more distinct bands (Figure 4.2c).
A novel class of detergent maltose neopentyl glycol (MNG) [120] used
in Paper 3 proved to be an ideal choice of detergent for solubilization and
purification. Its head and tail are fused to a central quarternary carbon
derived from neopentyl glycol. Two maltose units are connected to this
central atom and form a hydrophilic head. The other side of the central
carbon is occupied by two n-decyl chains forming a hydrophobic tail. This
detergent has the advantage of having a lower CMC value compared to
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other conventional alkyl-glycoside like DDM.
4.3 Chromatography and Purification
The chromatographic method in protein purification aims to separate the
desired protein from contaminants. Immobilized metal affinity chromatog-
raphy (IMAC) is the first purification step used to separate the recombinant
protein after the solubilization process. The main idea is to introduce a
unique chemical feature such as poly-histidine tag in the desired protein
through recombinant DNA techniques. The most widely used is the poly-
histidine tag comprising a string of six to ten histidine residues. Usually
the histidine tag is located at its N- or C- terminus making it readily acces-
sible for transition metal ions (Ni2+, Co2+, Cu2+, Fe2+ and Zn2+) immobi-
lized by a chelating ligand (nitrilotriacetic [NTA], iminodiacetic [IDA]) in a
matrix. In the TRAP transporters the six consecutive histidine amino acid
residues are inserted before the N-terminus of the membrane protein. The
Ni-NTA IMAC method was applied in this thesis and it proved to be highly
efficient and a fast purification step.
Size exclusion chromatography (SEC), as it name suggests, separates
protein molecules by their size. Large molecules are eluted first as they
cannot occupy the porous volume of the stationary phase while the small
molecules pass through porous bead volume delaying its elution time. Large
aggregates of protein molecules travel in the most mobile void volume and
they are eluted first. SEC can also be used to evaluate the homogeneity of
the purified protein. Conformational homogeneity of the desired protein is
an important requirement in crystallization and it is indicated with a sharp
and narrow Gaussian peak in SEC. Multimodal or broad peaks usually in-
dicate oligomers or the presence of more than one population. Thus, SEC
is an important tool for evaluating the homogeneity of the desired protein
before proceeding with crystallization.
The detection of protein can occur with UV absorption at 280 nm wave-
length. Alternatively, if the protein is tagged with a fluorescent protein tag
the emission of the tag is detected at 512 nm. This technique is flourescence
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Figure 4.5: Flourescent size exclusion chromatography (FSEC) profiles of
TRAP transporters. A. FSEC profile from the pWarf(+)Fn construct. B. FSEC
profile from the pWarf(+) Hi construct. C. FSEC profile from the pWarf(+)
VC construct .
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Figure 4.6: Results from the purification of Vc TRAP in the pBad system.
A. Western Blot after IMAC purification and using DDM and MNG-12 as
detergents. B. SEC elution profile and SDS PAGE using MNG-12 detergent.
size exclusion chromatography (FSEC)[121]. Although fluorescent proteins
tend not to affect the stability of the tagged protein, adverse effects cannot
be excluded. Initially, FSEC was used in detergent screening of TRAP trans-
porters (Figure 4.5). With the exception of MNG12-treated membranes, all
detergent treatment of Vc-TRAP protein resulted in aggregation. This con-
clusion was drawn from the large amount of protein observed in the void
volume. For Fn TRAP, the broadness of the elution peak is an indication of
dimeric or oligomeric states of the protein. Sharp Hi TRAP elution profiles
indicate monodispersity in the cases where the membranes were treated
with detergents DDM and MNG12 (Figure 4.5).
Fn TRAP in pWarf construct was purified with MNG12 detergent. How-
ever, the cleavage of the GFP fusion at the HRV3C site was unsuccessful af-
ter testing different concentrations of the protease (result not shown). Most
likely, the HRV3C site was inaccessible for the protease because it is buried
inside the Fn TRAP fold. The purification of the pWarf constructs therefore
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Figure 4.7: Results from the purification of Pm TRAP in pBad system. A. SEC
elution profile when using the detergent DM. B. SEC elution profile when
using the β-OG detergent. C. SEC elution profile and SDS PAGE using the
MNG-12 detergent.
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stopped at this point since Vc and Pm pBad constructs were more success-
ful during purification. Moreover, Pm in pBad had promising results in
the sparse matrix crystallization screen. I did not have the time nor the re-
sources to pursue both pBad and pWarf systems at the same time. For this
reason, I opted to invest my time and energy on pursuing the Vc and Pm
pBad constructs.
Unlike the other screened TRAP transporters orthologues, Vc TRAP’s
Q and M transmembrane domains were not fused and are transcribed by
two separate open reading frames (ORF). Western Blot analysis after IMAC
shows that more distinct bands are observed for the Q domain as the his-
tidine tag is located upstream the domain. Weak bands are discernible for
the QM domain indicate that intact QM domain population is purified but
the M domain could be solubilized during SDS treatment (Figure 4.6a).
SEC elution profile for Vc TRAP complex MNG12 detergent indicate
a stable profile with a small shoulder (Figure 4.6b). For Pm TRAP, SEC
elution profile complexed with MNG 12 detergent shows monodispersity
compared to Pm TRAP in DM and β-OG detergent (Figure 4.7a and b). Pm
TRAP-MNG12 complex was used for crystallization (Figure 4.7c).
4.4 Membrane protein crystallizability
Crystallizability is an important quality when evaluating membrane pro-
tein overexpression, solubilization and purification. In Paper 3, we de-
scribed that Pm TRAP transporters which crystallizes in five different con-
ditions. The crystals diffracted to 15-11 Å resolution which is a promising
indication (Figure 4.8). For near atomic resolution structure determination
more ordered crystals are needed. To increase the crystalline order, opti-
mization of crystallization conditions is needed which is highly empirical
and time consuming. The presence of the detergent is an intrinsic hinder for
ordering of membrane proteins in the crystalline state. Therefore it is very
important to find the most suitable detergent for this purpose. The deter-
gents that form a broad collar around the membranes proteins hydrophobic
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Figure 4.8: Pm TRAP crystals from formed four different conditions
region can hinder protein-protein contacts. This is detrimental for the for-
mation of ordered crystal lattice [122, 123].
4.5 Summary
In this chapter, the path from cloning to diffracting quality crystals is de-
scribed. The basis of discussion is the membrane protein overexpression,
solubilization, purification and crystallization of sialic acid TRAP trans-
porters orthologues. This work is described in more detail in Paper 3.
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Chapter 5
Crystal Structure of a Sialic Acid
Transporter
5.1 Proteus mirabilis SiaT
In Paper 4, the first crystal structure of a sialic acid transporter from P.
mirabilis (Pm)SiaT is the first sialic acid is reported. Pm SiaT was deter-
mined at 1.95 Å and captured in an outward-facing conformation [124].
Moreover, the structure shows bound β-anomeric sialic acid and two sodium
ions. The first sodium ion is bound to the conserved Na2 site while the
second sodium ion is located in a novel sodium binding site designated
Na3 site. In agreement with the predicted in silico topology, Pm SiaT is
composed of 13 membrane spanning helices (Tm0 and Tm1-Tm12) with
the N-terminal located in the periplasm while the C-terminal is located in
the cytoplasm. The domain core structure (Tm1-Tm5) and (Tm6-Tm10) has
inverted repeat motif which resembles the same fold as vSGLT [67], LeuT
[68]) and BetP [125](Figure 5.1).
The expression, solubilization and purification of Pm SiaT shares the
same principle as the expression, solubilization and purification of the TRAP
transporters in GFP fusion. After IMAC purification the GFP tag was cleaved
and then loaded onto HisTrap column. After SEC, the purified Pm SiaT was
crystallized through hanging drop diffusion method. The Pm SiaT crystal
structure was determined by the SAD method for experimental phasing.
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Figure 5.1: The overall structure of P. mirabilis sialic acid transporter adopt-
ing an outward facing conformation. Sialic acid is bound in the middle of
the transporter. (Reproduced from Wahlgren et al [124])
5.2 SiaT sialic acid binding site
That SiaT binds a β-anomeric sialic acid supports the hypothesis that the
transport system includes a mutarotase that converts the scavenged α-ano-
meric sialic acid to its β-anomeric form prior to its transport across the cy-
toplasmic membrane.
Sialic acid is bound in the core of the structure interacting with eight
key residues from the four helices (Tm1-Tm3 and Tm6) (Figure 5.2a). The
acetyl moiety of Neu5Ac located close to nonpolar residues Phe78 (Tm2),
Gly81 (Tm2) and Phe 243 (Tm6) while the hydroxyl group of its glycerol
tail interacts with Gln82 (Tm2) and Thr58 (Tm1). The carboxylate region of
Neu5Ac interacts with Ser60, Thr63 and forms a salt bridge with Arg135.
Consistent with the structural finding with the substrate-binding protein
SiaP from the TRAP transporters, a highly conserved arginine residue is
associated with the Neu5Ac specificity recognition [57, 59]. Additionally,
the presence of basic residue is a common feature of sugar-binding protein
[67] [126]. Mutation studies on the key residues along the substrate-binding
site (Thr58Ala, Ser60Ala, Thr63Ala, Gln82Asp and Arg135Glu) rendered
the transporter inactive with the exception of Thr58Ala, the least conserved
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Figure 5.2: P. mirabilis SiaT structure. A. The sialic acid binding site showing
sialic acid in coordination with key residues. B. The second sodium binding
site. (Reproduced from Wahlgren et al.[124])
residue in the binding site which has twice the uptake of the wild type
protein.
5.3 The sodium-binding site
There are two sodium ions bound to the structure. The Na2 site is 7 Å away
from the substrate-binding site and it is located between Tm1 and Tm8.
The sodium ion is coordinated by residues Ala56 and Leu59 (segment of
Tm1) and Ser342, Ser343 and Ala339 (Tm8). Transport assays on mutants
Ser324Ala and Ser343Ala indicate loss of uptake function.
The novel Na3 site that is 6.5 Å and 14 Å away from the Na2 site and the
substrate-binding site respectively. The sodium ion on Na3 site coordinates
with residues Ser342 (Tm8), Ser345, Ser346 and Asp182 (Tm5) (Figure 5.2b).
Mutations on key interacting residues on the Na3 site indicate varied de-
gree of transport. This signifies that mutations in the Na2 site rendered the
transporter inactive while a mutation in the Na3 site is not as detrimental.
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5.4 Alternating access mechanism
An alternating access mechanism for SiaT is proposed by constructing an
inward-facing model of SiaT based on the inward-facing structure of vSGLT
[126] . In this mechanism, the outer gate closes over the binding pocket as
Tm10 swings towards Tm1e and Tm2 leading to movement of Tm9 closer
to Tm3. During the process, the extracellular loop helices (Elh7a-Elh7b)
bend inwards towards Tm1e. The inward facing movement is predicted to
involve the movement of the intracellular loop/helix(Ilh0) from its closed
position, stabilized by salt bridges between conserved two conserved Arg
residues( Ilh0) with (Tm4i-Tm5 loop). Finally, the inner gate opens as the
intracellular loop (Ilh0) swings radially outward, away from the center and
simultaneously Tm8 and Tm9 rearrange by moving away from the inner
cavity.
The first crystal structure of the sialic acid transporter Pm SiaT eluci-
dates its function. The binding of a β-anomeric sialic acid by SiaT is consis-
tent with the involvement of a mutarotase in converting α-anomeric to β-
anomeric conformation before traversing the cytoplasmic membrane. Fur-
thermore, SiaT interpreted as an outward facing structure provides valu-
able insight into the alternating access transport mechanism employed by
the SSS family. One important aspect of the SiaT structure determination is
the discovery of a novel sodium binding site that is implicated in enhancing
the substrate-binding affinity and has a role in upholding structural stabil-
ity of the outward-facing conformation
5.5 Summary
In this chapter, the first crystal structure of a sialic acid transporter, P. mirabilis
SiaT was described in an outward-facing conformation and a novel second
sodium binding site was presented.
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Chapter 6
Concluding Remarks
This thesis presents work aimed at structural studies of enzymes or trans-
porters associated with the mechanism of sialic acid utliziation in bacteria.
As this work illustrates, the path to structure determination is paved with
many bottlenecks and hurdles. The purification of large quantities of high
quality recombinant protein is a key step in X-ray crystallography. Paper 1
describes an entirely automated pipeline for optimizing the cloning, expres-
sion and purification of several enzymes involved in sialic acid catabolic
and sialylation pathways. This approach led to the large-scale production
of FnNanK that was then used for crystallization.
In Paper 2, the crystal structure of apo FnNanK was determined at 2.2
Å resolution. FnNanK displays motifs intrinsic to the ROK superfamily but
lacks the distinctive zinc-binding region that has been implicated in stabi-
lizing the active site of this enzyme. For future studies, an FnNanK struc-
ture bound to a substrate and ATP analogues will elucidate the conforma-
tional changes that take place upon substrate binding. It would also be in-
teresting to compare the substrate binding mechanism of FnNanK to other
Nan kinase ortholgues known to have the zinc-binding region. Different
substrate analogues can also be co-crystallized with FnNanK to gain more
insight into the mechanism substrate binding. Since (to my knowledge) it is
still unclear if deleting FnNanK compromises the bacteria’s pathogenicity,
or if its function is salvaged by another mechanism in the pathway, it would
be important to perform these studies before deciding if this enzyme may
be interesting as an antibacterial drug target.
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In Paper 4, the first crystal structure of a sialic acid transporter was re-
ported at 1.9 Å resolution. Pm SiaT belongs to the SSS family of membrane
transporters that employs the alternating access mechanism when trans-
porting sialic acid into the cytoplasm. Since this structure captured the out-
wards facing conformation, it would be interesting to determine Pm SiaT
structures that adopt an inward-facing conformation and an occluded con-
formation, in order to understand better the transport mechanism through
the transporter. Moreover, the structure reveals a novel second sodium-
binding site that is suggested to enhance the substrate binding affinity and
to stabilize the outward facing conformation. It would be interesting to
compare Pm SiaT with other SiaT structures that also have a second second
sodium-binding site in order to better understand its cellular function.
In Paper 3, we described the process of membrane protein production,
detergent screening, purification and crystallization that started from the
broad-based screening of four TRAP transporter orthologues. This work
funneled down to Pm TRAP yielding diffraction quality crystals which
diffracted to low resolution. To push this project on towards structure deter-
mination, however, other crystallization methods may need to be be tried,
such as lipidic cubic phase crystallization or the use of bicelle crystallization
protocols. Another strategy to explore is to try single-particle cryo-electron
microscopy as structural determination method. The PmTRAP construct
with a GFP moiety is around 100 kDa in size and this is close to the min-
imum size where this method can usefully be applied. When in complex
with the substrate-binding subunit SiaP. The total size reaches 135 kDa,
which may be suitable for cryo-EM. Moreover, conditions may be found
where PmTRAP forms a stable higher oligomeric state, in which case the
size of the complex would not be the limiting factor for possible structural
determination. Regardless of the structural method used, the purification
of high quality, homogenous and stable protein remains the focal point for
any structural methods. The work presented here may thus serve as the
groundwork for future exploration.
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